References
- Chaieb K, Hajlaoui H, Zmantar T, Kahla-Nakbi AB, Rouabhia M, Mahdouani K, et al. The chemical composition and biological activity of clove essential oil, Eugenia caryophyllata (Syzigium aromaticum L. Myrtaceae): a short review. Phytother Res. 2007 ; 21 : 501-6. https://doi.org/10.1002/ptr.2124
- Gulcin I. Antioxidant activity of eugenol: a structure-activity relationship study. J Med Food. 2011 ; 14 : 975-85. https://doi.org/10.1089/jmf.2010.0197
- Burt S. Essential oils: their antibacterial properties and potential applications in foods-review. Int J Food Microbiol. 2004 ; 94 : 223-53. https://doi.org/10.1016/j.ijfoodmicro.2004.03.022
- Kurokawa M, Nagasaka K, Hirabayashi T, Uyama S, Sato H, Kageyama T, et al. Efficacy of traditional herbal medicines in combination with acyclovir against herpes simplex virus type 1 infection in vitro and in vivo. Antiviral Res. 1995 ; 27 : 19-37. https://doi.org/10.1016/0166-3542(94)00076-K
- Larhsini M, Oumoulid L, Lazrek HB, Wataleb S, Bousaid M, Bekkouche K, et al. Antibacterial activity of some Moroccan medicinal plants. Phytother Res. 2001 ; 15 : 250-2. https://doi.org/10.1002/ptr.815
- Shokeen P, Bala M, Singh M, Tandon V. In vitro activity of eugenol, an active component from Ocimum sanctum, against multiresistant and susceptible strains of Neisseria gonorrhoeae. Int J Antimicrob Agents. 2008 ; 32 : 174-9. https://doi.org/10.1016/j.ijantimicag.2008.03.018
- Gayoso CW, Lima EO, Oliveira VT, Pereira FO, Souza EL, Lima IO, et al. Sensitivity of fungi isolated from onychomycosis to Eugenia cariophyllata essential oil and eugenol. Fitoterapia. 2005 ; 76 : 247-9. https://doi.org/10.1016/j.fitote.2004.12.005
- Petersen LJ, Mosbech H, Skov PSJ. Allergen-induced histamine release in intact human skin in vivo assessed by skin microdialysis technique: characterization of factors influencing histamine releasability. Allergy Clin Immunol. 1996 ; 97 : 672-9. https://doi.org/10.1016/S0091-6749(96)70313-5
- Metzger H, Alcaraz G, Hohman R, Kinet JP, Pribluda V, Quarto R. The receptor with high affinity for immunoglobulin E. Annu Rev Immunol. 1986 ; 4 : 419-70. https://doi.org/10.1146/annurev.iy.04.040186.002223
- Alber G, Miller L, Jelsema CL, Varin-Blank N, Metzger H. Structure-function relationships in the mast cell high affinity receptor for IgE. Role of the cytoplasmic domains and of the beta subunit. J Biol Chem. 1991 ; 266 : 22613-20.
- Barsumian EL, Isersky MG, Petrino MG, and Siraganian RP. IgE-induced histamine release from rat basophilic leukemia cell lines: isolation of releasing and nonreleasing clones. Eur J Immunol. 1981 ; 11 : 317-22. https://doi.org/10.1002/eji.1830110410
-
Moriya K, Rivera J, Odom S, Sakuma Y, Muramato K, Yoshiuchi T, Miyamoto, M, and Yamada K. ER-27319, an acridine-related compound, inhibits release of antigen-induced allergic mediators from mast cells by selective inhibition of Fc
$\varepsilon$ receptor I-mediated activation of syk. Proc. Natl Acad Sci USA. 1997 ; 94 : 12539-44 (1997). https://doi.org/10.1073/pnas.94.23.12539 - Choi OH, Adelstein RS, and Beaven MA. Secretion from rat basophilic RBL-2H3 cells is associated with diphosphorylation of myosin light chains by myosin light chain kinase as well as phosphorylation by protein kinase C. J Biol Chem. 1994 ; 269 : 536-41.
- Metcalfe DD, Kaliner M, Donlon MA. The mast cell. Crit Rev Immunol. 1981 ; 3 : 23-74.
- Beaven MA, Rogers J, Moore JP, Hesketh TR, Smith GA, Metcalfe JC. The mechanism of the calcium signal and correlation with histamine release in 2H3 cells. J Biol Chem. 1984 ; 259 : 7129-36.
- Schwartz LB, Austen KF, Wasserman SI. Immunologic release of beta-hexosaminidase and beta-glucuronidase from purified rat serosal mast cells. J Immunol. 1979 ; 123 : 1445-50.
- Fischer MJ, Paulussen JJ, Horbach DA, Roelofsen EP, van Miltenburg JC, de Mol NJ, Janssen LH. Inhibition of mediator release in RBL-2H3 cells by some H1-antagonist derived anti-allergic drugs: relation to lipophilicity and membrane effects. Inflamm Res. 1995 ; 44 : 92-7. https://doi.org/10.1007/BF01793220
- Arbabi S, Maier RV. Mitogen-activated protein kinases. Cirt Care Med. 2002 ; 30 : S74-9. https://doi.org/10.1097/00003246-200201001-00010
- Beyaert R, Cuenda A, Vanden Berghe W, Plaisance S, Lee JC, Haegeman G, Cohen P, Fiers W. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J. 1996 ; 15 : 1914-23.